ZNF614 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.850820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.950800E-01
Normal-vs-Stage2
1.276970E-01
Normal-vs-Stage3
3.139900E-02
Normal-vs-Stage4
7.580400E-01
Stage1-vs-Stage2
3.011600E-01
Stage1-vs-Stage3
1.202220E-01
Stage1-vs-Stage4
8.465200E-01
Stage2-vs-Stage3
1.492340E-02
Stage2-vs-Stage4
3.324200E-02
Stage3-vs-Stage4
2.115100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.955960E-01
Normal-vs-AfricanAmerican
4.279600E-01
Normal-vs-Asian
4.414500E-02
Caucasian-vs-AfricanAmerican
6.383200E-01
Caucasian-vs-Asian
2.024800E-01
AfricanAmerican-vs-Asian
1.830580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.597410E-01
Normal-vs-Female
2.415400E-01
Male-vs-Female
2.611200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.180000E-01
Normal-vs-Age(41-60Yrs)
3.553200E-01
Normal-vs-Age(61-80Yrs)
1.233600E-01
Normal-vs-Age(81-100Yrs)
2.247600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.868000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.589600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.981600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.321900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.351600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.431800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.446320E-02
Normal-vs-Daily Drinker
1.367000E-01
Normal-vs-Weekly Drinker
4.150000E-02
Normal-vs-Occasional Drinker
3.809600E-01
Normal-vs-Social Drinker
3.399200E-01
Non Drinker-vs-Daily Drinker
3.300600E-01
Non Drinker-vs-Weekly Drinker
3.350400E-01
Non Drinker-vs-Occasional Drinker
6.882600E-03
Non Drinker-vs-Social Drinker
7.890200E-02
Daily Drinker-vs-Weekly Drinker
9.603400E-01
Daily Drinker-vs-Occasional Drinker
1.539810E-01
Daily Drinker-vs-Social Drinker
4.545200E-01
Weekly Drinker-vs-Occasional Drinker
1.162200E-01
Weekly Drinker-vs-Social Drinker
4.096600E-01
Occasional Drinker-vs-Social Drinker
6.172600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.296000E-01
Normal-vs-Grade 2
1.157020E-01
Normal-vs-Grade 3
1.587810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.499600E-01
Grade 1-vs-Grade 3
1.563590E-01
Grade 1-vs-Grade 4
2.296000E-01
Grade 2-vs-Grade 3
5.350600E-01
Grade 2-vs-Grade 4
1.157020E-01
Grade 3-vs-Grade 4
1.587810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.532200E-02
Normal-vs-NonDiabetic
1.735440E-01
Diabetic-vs-NonDiabetic
2.479800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.018900E-03
Normal-vs-NoPancreatitis
1.433360E-01
Pancreatitis-vs-NoPancreatitis
9.936000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.765010E-01
Normal-vs-N1
1.618430E-01
N0-vs-N1
8.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.592160E-01
Normal-vs-TP53-NonMutant
4.663600E-01
TP53-Mutant-vs-TP53-NonMutant
3.083200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
